Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2024-10-25 2024-12-03 241174
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
AURO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Resolved 2024-10-28 2025-04-23 241328
AURO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Resolved 2024-03-27 2024-07-30 223603
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 300MG 200MG 600MG TABLET Actual shortage 2025-04-14 2025-04-14 255042

Showing 11 to 20 of 37

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1